News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$HALB CEO, CTO and #YSU’s Dr. Sturrus Discuss CDC, Research Discoveries etc., on “The Street Reports Podcasts” Listen Now!https://t.co/vMi4rujZdY
— Halberd Corporation (@HalberdC) April 18, 2023
$HALB 🔥Youngstown, Ohio CBS #WKBN affiliate newscaster calls Halberd's patented technology success in eradicating Antibiotic-Resistant Bacteria and deadly Candida Auris pathogens, "Staggering"!#halberd #MedicalNews #candidaauris
— Halberd Corporation (@HalberdC) April 17, 2023
$HALB Halberd and YSU Interviewed on CBS Affiliate WKBN 5pm News as Research Advances
https://www.accesswire.com/749438/Halberd-and-YSU-Interviewed-on-CBS-Affiliate-WKBN-5pm-News-as-Research-Advances
JACKSON CENTER, PA / ACCESSWIRE / April 17, 2023 / Halberd Corporation's (OTC PINK:HALB) successful patent protected research being conducted at Youngstown State University (YSU) on antibiotic resistant bacteria and deadly Candida auris was recently featured in a news segment on Youngstown, OH CBS News affiliate television station, WKBN. Professors and student scholar lab assistants are conducting this intricate research on samples provided by the CDC (Centers for Disease Control and Prevention).
Dr. Cooper, Professor, Department of Chemical and Biological Sciences at YSU oversees the preparation of test samples of these antibiotic resistant bacteria. Researchers conjugate metallic nanoparticles and antibodies with an affinity for the target pathogens. Then they submit them to Dr. Sturrus' lab for laser exposure. Dr. Cooper's lab then evaluates the results after exposure to carefully crafted laser irradiation.
Dr. Cooper stated, "Then we take the bacteria out and try to grow them again. And, we find out that we are killing 90 - 95% of them … and leave the good bacteria alone" This was accomplished in under 10 minutes of laser exposure. These findings were recently presented to the CDC.
Dr. Sturrus, Chair and Professor, Physics, Astronomy Geology and Earth Science Department said of the students participating in the project, "When you talk atomic physics to students, they are sort of, 'What? Why?' But if you do something that kills bacteria, they're like, 'Hey! That's cool! I want to do that.'"
After learning of Halberd's success, the CDC offered to send additional potent strains of antibiotic resistant bacteria and fungi to YSU to be tested against Halberd's patented and patent-pending laser eradication methodology.
William A. Hartman, Halberd's Chairman, President & CEO added, "Using this technology, we will be treating disease (safely), outside of the body." This patented extracorporeal methodology, permits the extraction of infected bodily fluids for treatment prior to returning the cleansed bodily fluids to the body. Uniquely, the Halberd process is designed to accomplish this without potentially harmful antibiotics or drug side-effects.
I've been following BIEI and HALB for many years. This MSM news report is a first for them.
No, you didn’t get it, again!!! Bill Gates is the one dealing with Vaccines and other sort of pharma technology. Elon doesn’t get involved with such!!! Following a logic, it would make sense to bring up Gates instead because of involvement. Not saying it will happen
#PressRelase: $HALB Halberd Begins Preclinical Testing at Mississippi State University (MSU)
https://www.accesswire.com/748456/Halberd-Begins-Preclinical-Testing-at-Mississippi-State-University-MSU
$HALB Halberd Begins Preclinical Testing at Mississippi State University (MSU)
https://www.accesswire.com/748456/Halberd-Begins-Preclinical-Testing-at-Mississippi-State-University-MSU
JACKSON CENTER, PA / ACCESSWIRE / April 11, 2023 / Halberd Corporation (OTC PINK:HALB) has announced that preclinical testing is now underway at Mississippi State University (MSU) for its groundbreaking patent-pending nasal spray designed to suppress the negative effects of Traumatic Brain Injury (TBI). This innovative research involves the development of test mechanisms by MSU's staff to quantify and correlate the level of head impact to the degree of resulting brain injury, which has never been done before. Once these critical parameters are established, actual nasal spray testing will commence.
Halberd's approach to preventing the cascade of negative effects in the brain following head trauma is through the use of a proprietary blend of three active ingredients in a nasal spray, designed to block the excess production of certain identified inflammatory cytokines and neurotransmitters. MSU's pre-clinical tests aim to document the improvement in outcomes after brain injury from the administration of the nasal spray within hours of the traumatic event.
Halberd has previously stated that this project is fully funded by Epidemiologic Solutions Corporation, a 501 (c) (3) non-profit charity, enabling Halberd Corporation to proceed without the need for a partnership with Big Pharma or another partner. In compliance with MSU requirements, 75% of the estimated project costs have already been paid. The company is also working with mdi Consultants to ensure that testing and documentation conform to the FDA's strict requirements on the road to market approval.
The potential market for a product that proactively treats TBI through the suppression of excess neurotransmitters or inflammatory cytokines associated with brain trauma is enormous. Currently, no other product on the market addresses this need. If the test results are positive, this will be a significant step towards realizing Halberd's first therapeutic product, with enormous potential.
I'm pretty sure I meant to say Elon. But I'll take either as long as they bring their money.
$HALB Progress- MoneyTV with Donald Baillargeon
I think you meant to say Bill Gates, mate
Ebola-like Marburg virus
Lets see if you can kill this one Mr. Hartman
All good news. How about contacting Elon M. He might have some interest in this cutting edge technology.
$HALB Halberd's Successful Meeting with CDC Leads to Expanded Testing of Antibiotic Resistant Pathogens
https://www.accesswire.com/747204/Halberds-Successful-Meeting-with-CDC-Leads-to-Expanded-Testing-of-Antibiotic-Resistant-Pathogens
JACKSON CENTER, PA / ACCESSWIRE / April 3, 2023 / Halberd Corporation (OTC PINK:HALB) on March 29th met with five representatives from the Centers for Disease Control and Prevention (CDC). The CDC discussed Halberd's incredible success eradicating multiple strains of antibiotic resistant (AR) E. coli bacteria and deadly Candida auris samples previously provided by the CDC. Halberd participants presented the repeated success in eradicating these pathogens in the testing conducted at Youngstown State University (YSU) by a team led by Drs. Chester Cooper and W. Gregg Sturrus.
Dr. Cooper, Professor, Department of Chemical and Biological Sciences at YSU, led off the meeting recounting the type and number of strains of antibiotic resistant bacteria and fungi which the CDC previously provided and the process used to prepare the various strains and evaluate them after testing. Dr. Sturrus then described in detail Halberd's test results and procedure for using a tuned laser to selectively eradicate target antigens during the hour-long meeting. This built on the results Dr. Sturrus outlined in a recent TEDTalk:
This is from FOX NEWS today:
The CDC is sending personnel to assist with the outbreak of the Marburg virus in Guinea and Tanzania.
The virus is a rare and deadly disease which causes fever, chills, muscle pain, rash, sore throat, diarrhea, weakness or unexplained bleeding or bruising.
Thank you goingUPagain. Spot on!
I am not computer savvy and honestly don't know how to do that. If you go on YouTube and search TEDx-Youngstown-Dr. Sterrus it will come up.
HALB: So their CEO said that HALB's (purported) "meeting" with the CDC&P was merely, "VERY SUCCESSFUL"???? What????!!!! You mean that he DIDN'T this time say that said (alleged) "meeting' was a "MILESTONE" event; or a "WATERSHED" turning point; or a "BENCHMARK" occurrence; or an "UNPRECEDENTED" development in the history of MEDICAL SCIENCE, this time around????????????????
And, yet MORE (so-called) news, to boot???!!! This time, about a clever NASAL SPRAY --- are they KIDDING us??? --- to fix "traumatic head injuries"???? LAUGH-MY-MUTHA-DUCKING-ASK-OFF!!!!! Hey, HALB!!! How about a simple MOUTH SPRAY, to fix spontaneous HEART ATTACKS!!!!
Here is some legitimate DD. On YouTube there is a TEDx Youngstown video by Dr. Sturrus that explains in great, understandable detail what Halberd Corporation is working on. It is well worth ten plus minutes of your time to get a handle on things
From today’s pr:
The benefits of such an approach in treating head injuries to military personnel, contact sports athletes and ordinary people who experience head trauma are monumental
OK.. thinking of the military& athletes especially.. the nasal spray can be administrated when& where the injury occurs.. a big plus!
HOLY COW! Enough said.
Halberd Corporation and Mississippi State University sign agreement to start animal testing under the direction Dr. Russell Carr on April 10th, 2033 and expect to finish October 10th, 2023. Wow, wow, wow!
Key words in tweet: "VERY SUCCESSFUL" .
Looking good
$HALB Halberd and Mississippi State University (MSU) Sign Agreement to Conduct Pre-Clinical Model Tests of Nasal Spray to Block Negative Effects of Head Trauma
https://www.accesswire.com/746622/Halberd-and-Mississippi-State-University-MSU-Sign-Agreement-to-Conduct-Pre-Clinical-Model-Tests-of-Nasal-Spray-to-Block-Negative-Effects-of-Head-Trauma
JACKSON CENTER, PA / ACCESSWIRE / March 30, 2023 / Halberd Corporation (OTC PINK:HALB) and Mississippi State University (MSU) signed an agreement outlining the testing in pre-clinical models which will be conducted at MSU. The testing will focus on Halberd's patent-pending nasal spray designed to mitigate the effects of Traumatic Brain Injury (TBI), when administered shortly after sustaining head trauma. The work will be conducted starting April 10, 2023 and is expected to be completed by October 10, 2023 and will be under the direction of Dr. RussellCarr, of the College of Veterinary Medicine, as the Principal Investigator.
A traumatic head injury initiates a cascade of over-production of certain proteins and inflammatory cytokines in the brain. This over-production, depending on the magnitude of the injury, often manifests itself in neurological changes in behavior, such as PTSD, aggression and suicidal thoughts. Halberd's nasal spray is designed to counteract these TBI-related complications by blocking the over-production mechanism and allowing the brain to recover naturally. The benefits of such an approach in treating head injuries to military personnel, contact sports athletes and ordinary people who experience head trauma are monumental.
Dr. Mitchell S. Felder, Halberd's Chief Technology Officer and a board-certified attending neurologist stated, "Our patent-pending formulation combines three primary ingredients working in concert to counteract the pathophysiologic changes which occur in traumatic brain injury."
Dr. Carr stated "This approach of simultaneously targeting multiple pathways involved in the onset of damage following traumatic brain injury is extremely innovative and incorporating the delivery of this therapeutic into a nose spray should greatly enhance its effectiveness. We are pleased to be involved in the development of this strategy for the treatment of TBI and are excited about its potential."
William A. Hartman, Chairman, President & CEO of Halberd Corporation, added, "This agreement was due in a large part to the efforts of David Wilson, a licensed Professional Counselor, entrepreneur, and a Halberd Advisor/Consultant working closely with Dr. Carr and Halberd's technical staff, to bring this agreement to fruition. Because of the complexity of this experimentation and its revolutionary nature, this agreement has taken considerable time and effort in the planning. We are very pleased to have come to an agreement with Mississippi State University and look forward to a successful outcome."
Looking great! halb$!!
The meeting went well with 5 doctors from the CDC. PR to follow next week.. Definitely looking better. There is a great TED talk video with Dr. Sturrus regarding Halberd Corporation.
HALB: Indeed, Sir!!! And below, see a recent FILM-CLIP of the Great HALB CEO, Mr. HARTMAN himself --- proudly raising a 16-ounce GLASS of his OWN Urine; which he had EXTRA-CORPOREALLY disinfected with his disruptive, revolutionary, NANO-LASERS technology!!! And then boldly GULPED-IT-DOWN at HALB's recent "meeting" with the Head of the US CDC&P!!!!
HALB: Hey, CUTE Petri Dish!!! LOVE-IT!!! What's on it??? EXTRA-CORPOREAL Mice feces --- all cleaned-up with HALB's LASERS??? And, when HALB puts that back into the Mice, they will never again experience DIARRHEA, nor CONSTIPATION?????? Just think of the applications for us HUMANS --- especially after having had dinner at TACO BELL!!!!!
HALB: You get an A++ for your subtle SARCASM, Sir!! I'll give-ya THAT!!! (Now go get some EXTRA-CORPOREAL sleep & rest.)
HALB: In TRUTH, it is always HALB "Company" that is "JESTING", Sir --- and far beyond any JESTING that Mr. Shakespeare ever did in his WILDEST Comedies!!
(responsible mod: Bill Moynihan/EHRjunkie)
AI
